Previous close | 52.54 |
Open | 52.54 |
Bid | 52.00 |
Ask | 60.90 |
Strike | 430.00 |
Expiry date | 2026-01-16 |
Day's range | 52.54 - 52.54 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Vertex Pharmaceuticals ( NASDAQ:VRTX ) First Quarter 2024 Results Key Financial Results Revenue: US$2.69b (up 13% from...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]